The development of the vertebrate face is a dynamic multi-step process which starts with the formation of neural crest cells in the developing brain and their subsequent migration to form, together with mesodermal cells, the facial primordia. Signalling interactions coordinate the outgrowth of the facial primordia from buds of undifferentiated mesenchyme into the intricate series of bones and cartilage structures that, together with muscle and other tissues, form the adult face. Some of the molecules that are thought to be involved have been identified through the use of mouse mutants, data from human craniofacial syndromes and by expression studies of signalling molecules during facial development. However, the way that these molecules control the epithelial-mesenchymal interactions which mediate facial outgrowth and morphogenesis is unclear. The role of neural crest cells in these processes has also not yet been well defined. In this review we discuss the complex interaction of all these processes during face development and describe the candidate signalling molecules and their possible target genes.
Introduction
Whilst much attention has been paid to the embryonic origin of the facial structures and pathways of neural crest migration (Johnston, 1966; Le Lièvre and Le Douarin, 1975; Le Lièvre, 1978; Noden, 1975 Noden, , 1978 Noden, , 1988 Couly and Le Douarin, 1985 Lumsden et al., 1991; Couly et al., 1993a Couly et al., ,b, 1995 Le Douarin et al., 1993; Scherson et al., 1993; Köntges and Lumsden, 1996) very little is known about the mechanisms which control outgrowth and patterning of the facial primordia. Thus, regions within the facial primordia responsible for co-ordinating the development of surrounding tissue have not been identified. Such signalling centres and interactions have been identified for other vertebrate structures such as the limb, somites and the notochord/neural tube from results of experiments in which ectopically transplanted tissues modified the development of neighbouring tissues. The majority of these experiments have utilized the developing chick embryo as a model system, partly because it is accessible to manipulation in ovo. Signalling interactions that control patterning of the facial primordia have received far less attention because the later developing face is less accessible in ovo.
Facial structures are derived from the facial primordia, which are initially a number of discrete buds surrounding the primitive oral cavity, consisting of a neural crest-and mesodermally-derived mesenchymal core covered by an epithelial layer of ectoderm and endoderm (Fig. 1A) . Skeletal structures are derived from the neural crest, whilst the mesoderm gives rise to myoblasts and angioblasts (Noden, 1978 (Noden, , 1983 (Noden, 1988 Couly et al., 1995) . The neural crest cells arise within the peripheral neural ectoderm early in development and subsequently migrate into the presumptive facial primordia. In the chick, neural crest cells from regions anterior to rhomobomere 3 are the source of the developing facial primordia (Johnston, 1966; Le Lièvre and Le Douarin, 1975; Le Lièvre, 1978; Noden, 1975 Noden, , 1978 Lumsden et al., 1991; Scherson et al., 1993; Köntges and Lumsden, 1996) .
The lower jaw is formed from the paired mandibular primordia whilst the upper jaw is formed from the frontonasal mass, lateral nasal process and maxillary primordia (Fig. 1A ). In the upper jaw, analysis of the rat Pax-6 mutant has given us some insight into which skeletal elements are formed from each primordia but a definitive study in a normal embryo has not been done (see Fig. 1B and Osumi- Lillie, 1952) . Cartilaginous elements are marked in blue whilst membrane bones are red. Proximal elements are on the left. The maxillary primordia give rise to the pterygoid, palatine, quadratojugal and jugal. Based on data from the rat Sey mutant (Osumi-Yamashita et al., 1997) , the maxillary primordia probably also gives rise to maxilla and the premaxilla whilst the lateral nasal primordium gives rise to the lateral nasal wall, nasal and lachrymal bones. The frontonasal mass gives rise to the nasal septum. The mandibular primordia give rise to the skeletal structures of the lower jaw. In the chick, distal facial structures are formed from mid-brain crest whereas the more proximal elements such as the pterygoid and quadratojugal are derived from a mixture of midbrain and rhombomeric crest (Couly et al., 1996; Köntges and Lumsden, 1996) .
a Yamashita et al., 1997) . The skeletal structures from each of the facial primordia are connected with those formed from neighbouring primordia. For example, the maxillary primordium forms several bones in a 'proximo-distal' sequence. The most proximal structures articulate with the Meckels' cartilage derived from the mandibular primordia, whilst the distal structures are joined to the skeletal structures derived from the frontonasal mass (Fig. 1B) . Thus, growth and morphogenesis of the primordia must be tightly co-ordinated to obtain a normal and functional facial skeleton. Abnormal development of the facial primordia can result in many human syndromes such as Treacher-Collins and Alagilles syndrome, but more commonly cleft lip and palate, the latter of which affect one in 750 of live births (reviewed by Winter, 1996 ; see also Johnston and Bronsky, 1995; Thorogood, 1998) . Both ectodermal and mesenchymal factors control patterning and growth during many developmental processes. For example, during limb development, Wnt-7a and Engrailed-1 (En-1), which are expressed in the dorsal and ventral ectoderm, respectively, control patterning along the d-v axis, whilst patterning along the a-p axis can be determined by mesenchymal expression of Shh (reviewed by Johnson and Tabin, 1997) . Outgrowth of the developing limb bud is maintained by the expression of members of the FGF family in the ectoderm at the distal tip. Signalling interactions along all three axes are also co-ordinated; Wnt-7a and Fgfs can maintain the expression of Shh in the mesenchyme, whilst Shh can maintain the expression of Fgf-4 in the AER (reviewed by Johnson and Tabin, 1997) . Although some of the molecules involved in these patterning events have been identified, these signalling regions were first elucidated by classical embryological studies in which pieces of limb mesenchyme were grafted ectopically into different regions of the developing limb bud and in experiments in which the limb ectoderm was removed or rotated (reviewed by Tickle and Eichele, 1994) . Some of the equivalent experiments have been done with the facial primordia and these have shown that the outgrowth of the facial primordia requires epithelialmesenchymal interactions (Wedden, 1987) . However, to date, such experiments have not implicated any specific region(s) of mesenchyme or ectoderm which control patterning of the developing facial primordia. As in the developing limb, the facial primordia have three axes and signalling information must be co-ordinated to control growth and patterning. Thus, it would seem likely that there must be specific control regions of the developing facial primordia.
Our understanding of facial development is also hindered as it is a multi-step process involving the formation and migration of neural crest followed by the correct outgrowth of the facial primordia and the ultimate morphogenesis and differentiation of the skeletal elements. Many factors involved in facial development are expressed during a number, if not all, of these processes. Therefore, when facial abnormalities occur due to mutation of a gene, it is often not known which stages of facial development have been affected. Furthermore, as brain and facial development are interlinked, either directly through inductive interactions, or due to secondary effects of the changing shape of the developing brain and skull, it is not always apparent if facial abnormalities due to mutation of a gene are a direct effect on facial development, or are secondary due to abnormal brain development (reviewed by Opitz and Gilbert, 1982;  see also Le Douarin, 1985, 1987) .
Much previous work has focused on the roles of retinoic acid during facial development. Retinoic acid plays a key role in the developing facial primordia, as shown by knockout studies of retinoic acid receptors in mice (Lohnes et al., 1994) . Retinoic acid can also be teratogenic in excess and can modulate the expression of genes during facial development (reviewed by Morriss-Kay, 1993; Morriss-Kay and Sokolova, 1996 ; see also Lee et al., 1995; Brown et al., 1997; Helms et al., 1997; Iulianella and Lohnes, 1997) . Although important, since the function and effect of retinoic acid during facial development has been well reviewed elsewhere (Morriss-Kay, 1993; Morriss-Kay and Sokolova, 1996; Brickell and Thorogood, 1997) , in this review we will focus on the current knowledge of signalling factors and homeobox-containing genes that are expressed in the developing facial primordia. We first present the current knowledge of these factors during facial development and then present current thinking and knowledge within the field of tissue interactions during facial development. Finally, we present areas that are still not understood during facial development which are important areas for future research.
Signalling factors during facial development
Secreted factors that appear to be involved in facial development include members of the fibroblast growth factor (FGF), transforming growth factor b (TGFb), hedgehog (hh) and wingless (Wnt) gene families. Signalling molecules such as endothelin 1 (ET-1), platelet-derived growth factor A (PDGFa), epidermal growth factor (EGF), TGFa, stem cell factor, and membrane bound ligands such as jagged 1 and 2 (serrate 1 and 2) are also involved in facial development (Table 1; Fig. 2 ; see below for references and Lee et al., 1985; Pratt, 1987; Wilcox and Derynck, 1988; Coffin-Collins and Hall, 1989; Matsui et al., 1990; OrrUrtreger et al., 1990; Kronmiller et al., 1991; MorrisonGraham et al., 1992; Orr-Urtreger and Lonai, 1992; Shum et al., 1993) .
Some of these factors are expressed at several stages of face development and it is not always clear which stages of development are affected by mutation of a gene. A summary of the expression of these genes is presented in Table 1 , while the factors that have been shown to be involved in specific stages of face development are summarized in Fig.  2 .
Fibroblast growth factor family
The FGF family consists of at least 18 members. They are proliferative factors and in vitro studies have suggested that they may also have roles controlling cell differentiation, survival and motility (reviewed by Basilico and Moscatelli, 1992) . At least six members of the FGF family, are expressed in the developing facial primordia. Of these, Fgf-2, -4 and -8 are expressed in the epithelium. Fgf-2 is expressed throughout the epithelium of the chick facial primordia, while Fgf-4 and -8 are expressed in restricted regions (Drucker and Goldfarb, 1993; Crossley and Martin, 1995; Wall and Hogan, 1995; Vogel et al., 1996; Barlow and Francis-West, 1997; Helms et al., 1997; Richman et al., 1997) . FGFs can partially substitute for epithelial signals in their ability to support outgrowth of the facial primordia and FGF-2 can increase proliferation in micromass cultures of the frontonasal mass primordia (Richman and Crosby, 1990; . This suggests that members of the FGF family may control outgrowth of the developing facial primordia, analogous to the role of FGFs during development of the limb bud. Furthermore, transgenic expression of the extracellular ligand-binding domain of FGFR2b, which acts as a dominant-negative receptor, results in the development of cleft palate and a smaller face and skull (Celli et al., 1998) . FGFR2b normally binds FGF2, -3, -7 and -10, suggesting that some of these ligands are involved in facial development.
Expression of other members of the FGF family has not been fully characterized. Expression of Fgf-1 and -5 have been detected by Northern analysis of E13.5 developing mouse faces (Hébert et al., 1990) . In situ analysis at this stage has shown that Fgf-5 is expressed in regions of muscle formation in the developing face, suggesting a role in myogenesis, as has been proposed for FGF-5 in other regions of the developing embryo (Hébert et al., 1990; Haub and Goldfarb, 1991) . Fgf-12 is expressed in the mouse craniofacial mesenchyme between E10.5-14.5 but a detailed expression pattern for this gene has not yet been reported (Hartung et al., 1997) .
The fibroblast growth factor receptors, Fgfr-1, -2 and -3 are expressed in the mesenchyme of the facial primordia and are later associated with some regions of chondrogenesis (Wanaka et al., 1991; Peters et al., 1992; Yamaguchi et al., 1992; Patstone et al., 1993; Matovinovic and Richman, 1997; Wilke et al., 1997) . In humans, there are several craniofacial syndromes that are due to mutation of the FGF receptors (reviewed by Muenke and Schell, 1995; Yamaguchi and Rossant, 1995; Wilkie et al., 1995; Wilkie, 1997) . For example, Crouzon's syndrome and achondroplasia, both in part characterized by a smaller midface, are due to constitutive activation of FGFR2 and FGFR3, respectively (Jabs et al., 1994; Reardon et al., 1994; Meyers et al., 1995) . Apert's syndrome, caused by a missense mutation in the FGFR2 gene, is characterized by craniosynostosis, the premature fusing of the skull and the formation of hypoplastic zygomatic arch, maxillary and nasal bones (Cohen and Kreiborg, 1996) . While the facial defects in these syndromes are in part a secondary consequence to changes in skull development, they may also be due to direct changes in facial outgrowth and facial skeletal development. 
TGFb superfamily
The TGFb signalling family is a multi-gene family which includes the TGFb-1, -2 and -3 molecules themselves, and more distantly related members such as the bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs) and activins/inhibin family. Many members of this family and their receptors are expressed in the developing facial primordia (see references below and Dewulf et al., 1995; Roelen et al., 1997) . During development, members of this family have been shown to be involved in patterning, epithelial-mesenchymal interactions, cell proliferation, apoptosis and chondrogenesis (reviews by Kingsley, 1994; Hogan, 1996; Moses and Serra, 1996) . They are secreted molecules that act as dimers. Although there is some functional evidence to suggest that they act as heterodimers in vivo (Thomas et al., 1997) , it is not yet clear if they always act as heterodimers and which combinations of heterodimers they form. Tgfb-1, -2 and -3 are all expressed in the early facial mesenchyme, with later expression being associated with some regions of skeletal development (Pelton et al., 1989; Pelton et al., 1991; Millan et al., 1991) . The Tgfb-1 knockout dies before 10.5 days of embryonic development, so its role in facial development cannot be evaluated by this approach (Dickson et al., 1995) . In the Tgfb-2 knockout, there are defects in maxillary and mandibular development, occasionally resulting in cleft palate (Sanford et al., 1997) while in the Tgfb-3 knockout, there is always cleft palate. However, this is not due to abnormal development of the facial primordia or to the failure of the palatal shelves to form, as they do meet but fail to fuse (Kaartinen et al., 1995; Proetzel et al., 1995) . Thus, TGFb3 is specifically required for the fusion of the palatal shelves, which is consistent with its high level of expression at the palatal shelf interface. Recent work, has shown that TGFb3 promotes epithelialmesenchymal transformations of the touching epithelial seams in the palatal shelves (Kaartinen et al., 1997; Sun et al., 1998) . Indeed, even the palatal shelves of developing chick embryos, which do not meet in vivo and undergo partial transformation when placed together in vitro, can be induced to fuse in the presence of TGFb3, but not TGFb-1 or -2 (Sun et al., 1998) . Although Tgfb-3 is expressed in many other regions of the developing face, compensation by other members of the TGFb family may account for the normality of the remainder of the knockout face.
The expression of a few members of the BMP subdivision of the TGFb family have been characterized in detail (Francis-West et al., 1994; Bennett et al., 1995; Wall and Hogan, 1995; Barlow and Francis-West, 1997) . The function of three members of the Bmp (-2, -4 and -7) family has been knocked out in mice and there is a naturally occurring mutation in another member of the family, Bmp-5, resulting in the short-ear mutant (Kingsley et al., 1992) . The homozygous knockouts of Bmp-2 and Bmp-4 are not useful for facial studies as they die well before the formation of the facial skeletal structures (Winnier et al., 1995; Zhang and Bradley, 1996) . However, the chick model has given insight into the roles of BMP-2 and BMP-4 during facial development. In the early developing chick face, Bmp-4 is expressed in restricted domains in the epithelium in association with underlying regions of Bmp-2, Bmp-7, Msx-1 and Msx-2 expression in the mesenchyme (Fig. 3A,B ; FrancisWest et al., 1994; Wall and Hogan, 1995; Barlow and Francis-West, 1997 and our unpublished data) . Ectopic application of BMP-2 or BMP-4 can activate the expression of Msx-1 and Msx-2, which can also result in the bifurcation of skeletal structures ( Fig. 3C,E ; Barlow and Francis-West, 1997) . Furthermore, ectopic application of BMP-2 can increase proliferation in the mandibular primordia (Barlow and Francis-West, 1997) , whilst haplo-insufficiency of We have classed these processes as early patterning events that specify head mesoderm or control neural tube formation, control neural crest migration or regulate patterning and outgrowth in the facial primordia. Also listed are examples of genes that appear to be involved in these processes and their possible targets of action (see text for references). The assignation of genes to a particular process does not necessarily imply that it does not act at other stages of development. One example is Otx-2 which is also expressed in the migrating neural crest, so although it has a role in early development, this does not discount it from acting during later development. It should be emphasized that these genes do not affect all craniofacial structures, and that their effects are regionalized. One example is Pax-6, which controls development of anterior structures of the face. Another is ET-1, which controls the expression of Goosecoid only in the first and second arches. A list of other genes expressed during facial development is presented in Table 1 .
Bmp-4 in C57Bl/6 mice results in the formation of shorter frontal and nasal bones in 12% of heterozygous mice (Dunn et al., 1997) . Together, these data suggest that BMP-2 and BMP-4 may control outgrowth of the facial primordia.
Knockout of Bmp-7 in mice affects the development of some cranial bones and can result in the formation of a much smaller pterygoid bone (Dudley et al., 1995; . The lack of effect on most of the facial skeletal structures shows that Bmp-7 alone is not crucial for facial development and suggests that there is a functional redundancy between the BMPs. In the developing chick face, expression of Bmp-7 co-localizes with Bmp-2 expression (our unpublished data) as occurs in several regions of the developing embryo and it is possible that expression of Bmp-2 compensates for the lack of Bmp-7. (arrowed) is associated with the extension of Shh expression in the overlying epithelium (arrowed). In (C) the bead is marked by a white arrowhead. In (C) and (D), the normal domains of Msx-1 and Shh expression are shown on the right hand side of the embryo. These manipulations can result in the bifurcation or apparent duplication of skeletal structures. (E) shows the effect of placing a BMP-2 bead at the posterior edge of the maxillary primordia at stage 19. This would result in the extension of Msx-1 and Shh expression. On the treated side of the face, there is an additional skeletal structure which resembles the palatine because of its shape and contact with the pterygoid. For further details see Barlow and Francis-West, 1997 . md, Mandibular primordia; mx, maxillary primordia; p, palatine: pe, 'ectopic' palatine; pt, pterygoid.
The Bmp-5 mutant is characterized by shortened ears and a smaller skeletal structure (Green, 1951; Kingsley et al., 1992) . Bmp-5 is expressed in the developing cartilage elements and it is thought that the defects seen in the mutant are due to abnormal skeletal growth (Kingsley et al., 1992; King et al., 1994) . There is also a human syndrome, characterized by a similar phenotype such as ear defects and short stature, which has been proposed to be caused by mutation in the BMP5 gene (Lacombe et al., 1994) .
Activin bA, another member of the TGFb family, is expressed in the mesenchyme of developing mouse and rat faces (Feijen et al., 1994; Roberts and Barth, 1994) . Knockout of its function in mice results in cleft palate and loss of lower incisors (Matzuk et al., 1995a) ; the lack of skeletal abnormalities suggests that the cleft palate is due to a defect in growth of the facial primordia (Matzuk et al., 1995a) . A null mutation of follistatin results in hard palate abnormalities similar to those seen in activin bA knockout mice, suggesting that follistatin acts as an activin agonist in vivo, despite it acting as an activin antagonist in vitro (Matzuk et al., 1995b) . Follistatin can also act as a BMP-2/BMP-4 antagonist in vitro and the follistatin knockout has additional defects to those seen in the activin bA knockout in some regions of the body. This suggests that follistatin can modulate the activity of several members of the TGFb family. Knockout of the activin type 2 receptor, ActRcII, also causes craniofacial defects, including hypoplasia of the mandible and cleft palate in a low percentage of animals (Matzuk et al., 1995c) .
Hedgehog family
Three members of the Hedgehog family have been identified in humans, mice and chicks: Sonic hedgehog (Shh), Indian hedgehog (Ihh) and Desert hedgehog (Dhh) (reviewed by Hammerschmidt et al., 1997) . Shh signalling has been implicated in the patterning of several vertebrate structures including the limb bud, neural tube and somites, whereas Ihh is thought to control chondrocyte differentiation in developing cartilage elements. In developing mouse and chick faces, Shh is expressed in the epithelia of some of the facial primordia ( Fig. 3D ; Martí et al., 1995; Wall and Hogan, 1995; Barlow and Francis-West, 1997; Helms et al., 1997) . Knockout of Shh function in mice and mutation of the SHH gene in humans result in holoprosencephaly, characterized by abnormal forebrain and facial development Chiang et al., 1996; Roessler et al., 1996) . In the knockout mice, the skeletal structures of the face are almost completely absent, although the branchial arches do appear to be relatively normal at E9.5. As any perturbation in the development of the brain will have a knock-on effect on the face, it is not yet clear if Shh has a direct role in facial patterning. However, functional studies have shown that the facial epithelia which express Shh can induce digit duplications when grafted into the anterior region of a developing limb bud, showing that this facial epithelium does have patterning ability (Helms et al., 1997) .
Mutations in members of the hh signal transduction pathway can also result in facial abnormalities. In Drosophila, hh signals through the transmembrane receptor patched (ptc) and the transcription factor, cubitus interruptus (ci) protein (Alexandre et al., 1996; Domínguez et al., 1996) . A similar signalling cascade exists in vertebrates (see review by Ingham, 1998) . In humans, haplo-insufficiency of PTC results in Gorlin's syndrome which is characterized by cleft palate and odontogenic cysts in the mandible consistent with the expression of the Ptc homologues in the first branchial arch in mice and chicks Hahn et al., 1996a,b; Johnson et al., 1996; Unden et al., 1996; Platt et al., 1997) .
In vertebrates, there are at least three homologues of ci, known as Gli, Gli-2 and Gli-3 (Ruppert et al., 1988; Hui et al., 1994) . In the chick limb bud and Xenopus neural tube, Gli expression is induced by Shh and Gli is thought to mediate the downstream effects of Shh signalling, as in Drosophila (Marigo et al., 1996; Lee et al., 1997 ). In contrast, in the developing chick limb bud, Gli-3 is downregulated following Shh mis-expression and it is has been proposed that Gli-3 is a repressor of Shh expression (Masuya et al., 1995; Marigo et al., 1996 ; see review by Ruiz i Altaba, 1997). In the embryonic mouse face, Gli-2 and -3 are expressed in migrating neural crest and all three Glis are expressed in early facial mesenchyme, later becoming associated with skeletogenesis (Walterhouse et al., 1993; Hui et al., 1994) . If and how these genes mediate/ affect hedgehog signalling in the developing face is unknown. Knockout of Gli-2 and mutation of Gli-3 in mice results in facial abnormalities (Mo et al., 1997) . These phenotypes are distinct, with knockout of Gli-2 resulting in truncation of the distal part of the maxilla and mandible, the absence of the incisors and clefting due to the loss of the presphenoid bone, maxillary and palatine shelves (Mo et al., 1997) . In contrast, in the Gli-3 mutant, the maxillary region is enlarged, the external nasal processes are smaller and some clefting occurs. Double knockout of both Gli-2 and Gli-3 in mice has a more severe effect on mandibular development, with several additional bones being hypoplastic, suggesting that in some regions of the developing face, there is functional redundancy between Gli-2 and Gli-3 (Mo et al., 1997) .
In humans, partial loss of GLI3 function due to deletion or translocation of one copy of GLI3 results in Grieg's syndrome, which is usually characterized by a wide forehead and nasal bridge (Vortkamp et al., 1991) . The clinically distinct Pallister-Hall syndrome is associated with a mutation in GLI3 which truncates the protein (Kang et al., 1997) .
Wnt family
The Wnt gene family consists of at least 15 members.
They have been shown to have a number of roles during development, including patterning the central nervous system and the dorso-ventral axis of the limb bud (reviews by McMahon, 1992; Johnson and Tabin, 1997) and modulating chondrocyte differentiation in chick limbs and faces (Rudnicki and . At a cellular level, some members of the family have been shown to modulate cell-adhesion, proliferation and gap-junctional communication (Tsukamoto et al., 1988; Olson et al., 1991; Dickinson et al., 1994; Hinck et al., 1994; Bradley and Brown, 1995 ; see also review by Moon et al., 1993) . Wnt-5a, -10a, -10b and -11 are expressed in the developing facial primordia of mice, whereas expression of Wnt-1 and -2 has not been detected in similar studies (Gavin et al., 1990; Parr et al., 1993; Christiansen et al., 1995; Hollyday et al., 1995; Wang and Shackleford, 1996) . Wnt-5a and -11 have been shown to be expressed in the mesenchyme of the facial primordia by in situ hybridization (Parr et al., 1993; Christiansen et al., 1995; Hollyday et al., 1995) . Wnt -10a and -10b have been detected at 12.5 days of embryonic development by Northern analysis (Wang and Shackleford, 1996) but localization of their expression has not been determined. The roles of the Wnt genes during facial development are not yet known. However, knockout of Lef-1, a gene involved in Wnt signal transduction and which is expressed in the migrating neural crest and later in the facial primordia, results in the loss of teeth and the mesencephalic nucleus of the trigeminal nerve, although there are no detectable abnormalities in the skeletal structures of the face (Oosterwegel et al., 1993; van Genderen et al., 1994) .
Jagged
Jagged 1 and 2 (also known as serrate 1 and 2), membrane ligands for the notch receptor family, are known to have a role in facial development. In mice, jagged 1 is expressed in developing maxillary and mandibular primordia . In humans, haplo-insufficiency of JAGGED1 causes Alagilles syndrome characterized by a triangular shaped face resulting from defects in mandible, forehead and nose development (Alagille et al., 1975 (Alagille et al., , 1987 Oda et al., 1997) . Recently, truncated forms of serrate have been shown to act in a dominant-negative fashion during Drosophila wing development (Hukriede et al., 1997) . Although, some cases of Alagilles syndrome are due to truncation of the JAGGED1 protein which may act as dominant-negatives during facial development, it is most likely that Alagilles syndrome is due to haplo-insufficiency as loss of the JAG1 gene has the same phenotype as expression of the truncated forms.
Jagged 2 (serrate 2) is expressed in the epithelium of the 1st branchial arch in day 9 mouse embryos, with expression being detectable in other branchial arches by day 10 (Sidow et al., 1997; Valsecchi et al., 1997; Jiang et al., 1998) . In addition, expression of jagged 2 has been detected around the developing nasal pits. Mutation of jagged 2, which causes a single amino-acid change in the protein, is thought to be responsible for the mouse syndactylism (sm) mutant (Sidow et al., 1997) . This mutant is characterized by limb defects, but has no apparent facial abnormalities. However, complete knockout of jagged 2 function does result in facial defects, predominantly characterized by a failure of the palatal shelves to elevate which subsequently fuse with the developing tongue (Jiang et al., 1998) . In addition, in the jagged 2 knockout there are limb defects which are similar to but more severe than those in the sm mutant. This suggests that the sm mutation acts as a hypomorphic mutant allele and that the developing limb is more sensitive to changes in jagged 2 expression.
Endothelins
Endothelin 1 (ET-1) is a small polypeptide of 21 amino acids which is proteolytically activated by endothelin-converting enzyme (ECE-1). Both are expressed in the epithelium and paraxial mesoderm of developing first and second branchial arches, whilst one of the receptors for ET-1, EtA, is expressed in a complementary pattern, i.e. in neural crest derived mesenchyme (Kurihara et al., 1994; Barni et al., 1995; Maemura et al., 1996; Clouthier et al., 1998) . In addition, at earlier stages, EtA expression has been detected in migrating neural crest with expression of Ece-1 in the surrounding mesenchyme Yanagisawa et al., 1998) . The expression of the ligands of EtA (Et-1 and Et-2) during these early stages has not been reported. The Et-1, Ece-1 and EtA knockout mice have very similar phenotypes with the skeletal structures derived from the first and second arches being smaller and there is cleft palate (Kurihara et al., 1994; Clouthier et al., 1998; Yanagisawa et al., 1998) . Analysis of the Et-1 mutant arches shows that they are smaller at 10.5 days of embryonic development, suggesting that these abnormalities are, in part, due to an early defect in facial development. EtA is expressed in the migrating neural crest cells and if Et-1 is also expressed at this stage, this defect may arise during neural crest migration. Alternatively, this early abnormality could be due to changes in epithelial-mesenchymal interactions. Since ET-1 is mitogenic for differentiated melanocytes (Swope et al., 1995) and since another member of the endothelin family, ET-3, has been shown to increase proliferation of trunk neural crest, the defects in facial development in the Et-1 knockout mice are likely due to a decrease in proliferation of the cranial neural crest (Lahav et al., 1996; Stone et al., 1997) . This proposed mitogenic effect may be direct or may be by modulation of the expression/activity of other mitogenic factors. For example, in rat atrial cardiocytes, ET-1 increases the secretion of the endopeptidase 24.11, a zinc-containing metalloendopeptidase, which is expressed in craniofacial mesenchyme and modulates the activity of various signalling molecules either through proteolytic activation and/or degradation (Fukuda et al., 1988; Spencer-Dene et al., 1994) . The defects seen in the Et-1, Ece-1 and EtA knockout mice are similar to human syndromes collectively known as CATCH 22, which are characterized by face defects in addition to cardiac and other defects. It has been proposed that mutation in a component of the ET-1 signalling pathway may be responsible for some of the CATCH 22 syndromes .
PDGFs
PDGFs also have a role in facial development. Pdfga receptor (Pdgfra) is expressed in the migrating neural crest and facial mesenchyme, whilst its ligand, Pdgfa, is expressed in the epithelium of the branchial arches Orr-Urtreger and Lonai, 1992; Schatteman et al., 1992) . Knockout of Pdgfra results in midline defects and the under-development of the face with the loss of some bones, whilst neuronal derivatives of the neural crest are unaffected (Soriano, 1997) . At E10, there is increased apoptosis in the head and branchial arches and it has been proposed that PDGFa promotes survival of a subset of neural crest which give rise to non-neuronal derivatives (Soriano, 1997) .
To understand the roles of these signalling molecules during facial development, functional studies need to be performed to determine how members of these gene families control outgrowth and patterning and how these different signalling pathways interact. For example, do these different signalling factors/pathways control different aspects of facial patterning, as in the developing limb bud?
Target genes
Knockout studies have shown that homeobox-containing genes control the development and patterning of many structures and thus, homeobox-containing genes which are expressed in the developing face are strong candidates to control facial patterning. Genes of the Hox cluster, which have been shown to mediate patterning in the axial and appendicular skeleton (reviewed by Krumlauf, 1994a) , are not expressed during development of the facial primordia. However, Hoxa-2 is expressed in the neural crest derivatives that give rise to the second arch (Hunt et al., 1991b,c; Prince and Lumsden, 1994; Couly et al., 1996 ; reviewed by Hunt et al., 1991a; Krumlauf, 1994b ) and knockout of Hoxa-2 results in the transformation of second arch structures to form proximal first arch derivatives, showing that this Hox gene is involved in patterning the second branchial arch (Gendron-Maguire et al., 1993; Rijli et al., 1993) . Recent studies have shown that the expression of the Hox cluster genes are the same during craniofacial development in humans, mice and chick, confirming the validity of using mouse and chicks as models for understanding the role of HOX genes during human facial development (VieilleGrosjean et al., 1997) .
Although the classical Hox genes are not expressed in the developing facial primordia, several other homeobox-containing genes are expressed and these are therefore candidates for patterning the facial primordia. These genes include Msx-1 and 2, MHox, Dlx-1-6, Barx-1 and -2, Otx-2, GH6; Bicoid-homologues such as Gsc-1, Ptx-1 and Reig (also called Brx-1 and Otlx-2); the paired-box homologues, Pax-3, -6, -7, Cart-1 and the paired-related genes such as S8 and Uncx-4.1 (Table 1 and see below for references. Also see Opstelten et al., 1991; Stadler and Solursh, 1994; Tissier-Seta et al., 1995; Jones et al., 1997; Mansouri et al., 1997; Wu et al., 1997) . Many of these homeobox-containing genes are expressed in the neural-crest derived mesenchyme of the developing facial primordia, marking specific regions of the developing face. As the neural crest cells are classically thought to pattern the developing face (but see Section 5), much attention has focused on these genes as they may control patterning of the developing facial primordia. Knockout of several of these genes results in distinct defects in facial development, supporting this idea (see below; Table 2 and Fig. 4) . As different skeletal structures are affected by the various knock-outs, the combinatorial pattern of gene expression may pattern the developing face, as has been suggested for Dlx genes during development of the first branchial arch (Fig. 4 ; Qiu et al., 1995 Qiu et al., , 1997 . Of particular interest are Dlx-2, Mhox and Otx-2, whose knockout results in atavistic skeletal changes in the shape of bones and/or the formation of additional bones, such that they resemble those of more primitive ancestors (see references below). In addition to providing functional evidence that these genes play a role in patterning the facial primordia, this also suggests that either the evolution of these genes or their differential expression in different species has resulted in changes in the patterning of craniofacial structures (reviewed by Kuratani et al., 1997) .
In addition, to homeobox-containing genes expressed in the ectomesenchyme, others such as Tlx-1 and En-2 expression are thought to mark presumptive myoblasts in the first arch (Gardner et al., 1988; Davis et al., 1991; Logan et al., 1993; Raju et al., 1993; Dear et al., 1995) . As the neural crest-derived mesenchyme patterns the developing musculature, these genes are unlikely to have a direct role in facial patterning. This idea is supported by knockout of either Tlx-1 or En-2 in mice, which do not have any detectable consequences on face, including facial muscle, development (Millen et al., 1994; .
Expression of these homeobox-containing genes, together with those transcription factors that are known to be involved in facial development, is presented in Table 1 . As with the signalling factors, it is not always clear which stages of development are affected by mutations. However, genes known to be involved in specific aspects of development are shown in Fig. 2. 
Homeobox-containing genes

Msx genes
Msx-1 and Msx-2 are related to the muscle-segmentation gene msh in Drosophila. They are expressed in migratory and post-migratory neural crest and appear to mediate epithelial-mesenchymal signalling interactions (Hill et al., 1989; Robert et al., 1989; Mackenzie et al., 1991a,b; Suzuki et al., 1991; Mina et al., 1995) . Knockout of Msx-1 function in mice causes abnormalities in the development of all the facial structures, ranging from the loss of structures such as the shelves of the palatine and maxillary bones, to a slight shortening of other bones such as the maxilla and mandible ( Fig. 4 ; Table 2 ; Satokata and Maas, 1994) . In addition, the teeth do not develop beyond the bud stage (Satokata and Maas, 1994) . Msx-1/Msx-2 double mutant mice exhibit a more severe face phenotype, suggesting a functional redundancy between these two genes (R. Maas, pers. commun.).
There are human syndromes due to mutation in these genes. Mutation in one copy of the MSX1 homeobox domain in humans results in the loss of premolar and molar teeth, but there are no other detectable abnormalities in facial development (Vastardis et al., 1996) , whilst a mutation in one copy of the MSX2 gene, which increases the stability of binding of the protein to the MSX2 binding site, TAATTG, causes Boston-type craniosynostosis (Jabs et al., 1993; Liu et al., 1996; Ma et al., 1996 ; reviewed by Wilkie, 1997) . A similar phenotype is found in transgenic mice overexpressing the Msx-2 gene, again suggesting that increased activity of Msx-2 can cause craniosynostosis (Liu et al., 1995) .
Dlx gene family
The Dlx genes comprise a multi-gene family of at least six members in mice (Nakamura et al., 1996; Stock et al., 1996) . Based on their overlapping expression patterns and functional analyses, it has been proposed that they have a role in patterning the branchial arches (Bulfone et al., 1993; Akimenko et al., 1994; Robinson and Mahon, 1994; Simeone et al., 1994; ) . They are homologous to the Distal-less gene in Drosophila, which is required for the formation of the distal region of the legs, mouth parts and antennae (Cohen et al., 1989) . Dlx-1 and -2 are expressed in migratory neural crest. In mice, only Dlx-1 and Dlx-2 are expressed in the developing maxillary arch, whilst Dlx-1-6 are expressed in overlapping domains in the developing mandibular primordia (Dollé et al., 1992; Bulfone et al., 1993; Robinson and Mahon, 1994; Qiu et al., 1995 Qiu et al., , 1997 Zhang et al., 1997) . Knockout of Dlx-1 affects the development of the palatine and pterygoid bones, whereas knockout of Dlx-2 function in mice affects the development of these as well as the maxillary, squamosal and jugal bones ( Fig. 4 ; 
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The numbers next to the name of the element refer to the position of the element in the mouse skull shown in Fig. 4 . The data from the Pax-6 mutant is from analysis of the rat Sey/Sey mutant. It should also be noted that the defects listed for the Otx-2 mutant are for the heterozygous, not the homozygous, mutant. (+) Denotes skeletal structures of the mouse face and skull which can be affected by knockouts of various homeobox genes (see text for references). . The palatine bone is obscured by the maxilla; its position is marked only as a guide. For the sake of clarity, the basi-occipital and the petrosal bones have been omitted. As this a lateral view, more medial bones such as the presphenoid, orbitosphenoid and vomer are obscured. For details of the effects on these elements see Table 2 . Table 2 ; Qiu et al., 1995 Qiu et al., , 1997 . In the Dlx-2 knockout, there is an apparent replacement of alisphenoid with an ectopic cartilaginous structure which resembles the palatoquadrate of more primitive vertebrates. The squamosal and jugal bones also appear to be replaced by four bones. No additional skeletal structures are affected in the double knockout of Dlx-1 and Dlx-2. However, in these mutants, the maxillary molars do not form, showing a functional redundancy between Dlx-1 and Dlx-2 during the development of these teeth. The Dlx-1/Dlx-2 knockout skeletal defects are restricted to derivatives of the maxillary primordia suggesting that there is functional redundancy of Dlx-1 and-2 with other Dlxs in the developing mandibular primordia. It has been suggested that some of the changes seen in the Dlx-2 mutant are atavistic and that the evolution of Dlx-2 resulted in changes in the shape/pattern of the facial bones (Qiu et al., 1995 (Qiu et al., , 1997 .
Otx-2
Otx-2 is expressed in the migrating neural crest and the mesenchyme of the first arch and frontonasal mass in mice (Ang et al., 1994; Osumi-Yamashita et al., 1994) . Knockout of Otx-2 function usually results in death of the embryos before E10 with the homozygous mutants completely lacking the presumptive rostral head, indicating that Otx-2 is essential for head development (Acampora et al., 1995; Matsuo et al., 1995; Ang et al., 1996) . Haplo-insufficiency in the heterozygote mice results in a wide spectrum of defects, ranging from the lack of a head to malformed and smaller jaws ( Fig. 4; Table 2 ; Matsuo et al., 1995) . In some heterozygous mutants, there are changes in the alisphenoid and incus such that they resemble the more primitive palatoquadrate cartilage. Furthermore, there are other possible atavistic changes, such as the apparent representation of the nasal septum by two rod-like structures (Matsuo et al., 1995) .
Bicoid homologues
Two bicoid homologues, Goosecoid (Gsc-1) and Mhox, have been knocked out in mice which result in facial defects. As these genes are expressed in the facial primordia, but not at earlier stages of facial development, this shows that they are important in later stages of facial development such as controlling epithelial-mesenchymal interactions (Fig. 2) .
In mice, Gsc -1 is expressed in post-migratory crest in the developing facial primordia and knockout of its function in mice affects most of the facial region ( Fig. 4; Table 2 ; Gaunt et al., 1993; Rivera-Perez et al., 1995; Yamada et al., 1995) . A related homeobox-containing gene, pituitary homeobox-1, ptx-1, is expressed in a complementary pattern to Gsc-1 in the developing mandible and nasal cavities in E11.5 and E13.5 mice (Lanctôt et al., 1997) , although the significance of this is unknown. In humans, Rieger's syndrome, which has mild craniofacial deformaties including odontogenic abnormalities, is due to mutation in another bicoid-related homeobox gene, RIEG (Semina et al., 1996) . Analysis of the expression patterns of the mouse and chick homologues (known as Rieg, Brx-1 or Otlx-2), shows that it is expressed in the oral epithelium of the maxillary and mandibular primordia between E8.5-11 and at stage 18 of embryonic development, respectively (Semina et al., 1996; Kitamura et al., 1997; Mucchielli et al., 1997) . Therefore, the odontogenic defects and the facial abnormalities seen in Rieger's syndrome are likely due to defective epithelial-mesenchymal interactions. However, as Rieg is also expressed in the developing head mesoderm and later in the developing brain, it is also possible that these defects are due to defective mesoderm development and/or neural crest formation and migration.
Mhox (also called Prx-1) is expressed in the mesenchyme of the developing facial primordia in mice and chicks (Cserjesi et al., 1992; Nohno et al., 1993; Kuratani et al., 1994) . Knockout of Mhox function in mice affects the development of skeletal elements derived from the maxillary primordia and the proximal part of the mandibular primordia ( Fig. 4 ; Table 2 ; Martin et al., 1995) .
Paired-related genes
The paired box family consists of nine members which are transcription factors containing a conserved protein motif, the paired box and, with the exception of Pax-1 and-9, a homeobox or partial homeobox domain (reviewed by Dahl et al., 1997) . During development they are thought to have several roles, including controlling epithelialmesenchymal transitions, differentiation and proliferation. At least five members of the paired box gene family, , are expressed in the developing facial primordia (Goulding et al., 1991; Jostes et al., 1991; Walther and Gruss, 1991; Dietrich and Gruss, 1995; Grindley et al., 1995; Mansouri et al., 1996; Neubüser et al., 1995 Neubüser et al., , 1997 . To date, four Pax mutants or knockouts have been characterized. The small eye, Pax-6, mutant is the most well studied in terms of craniofacial development, and at least some of the facial defects are associated with abnormal neural crest migration (see references below). Studies of the Pax-3 mutant, splotch, have shown that Pax-3 controls trunk neural crest migration. Pax-3 and -7 are expressed in regions of the neural tube/developing brain which will give rise to neural crest and in the migrating neural crest cells themselves, raising the possibility the facial defects in these mutants/knockouts may be due to failure of epithelialmesenchymal transformations or neural crest migration, but this has yet to be determined.
The Pax-1 mutant, undulated, is not associated with the loss of facial skeletal structures, but they are shorter than normal and the angle between the upper and lower jaw is abnormal (Dietrich and Gruss, 1995) . As Pax-1 is expressed in the mesenchyme of the facial primordia, the Pax-1 face defects may be due to defective epithelial-mesenchymal interactions during later facial development.
The homozygous mouse Pax-3 mutant, splotch, does not have facial defects, possibly due to compensation by other members of the gene family that are expressed in similar regions (Morell et al., 1992) . However, on a different genetic background, there are craniofacial abnormalities in the splotch mutant and it has been suggested that at least two gene products interact to modulate the function of Pax-3 (Asher et al., 1996a) . Studies of its role in trunk neural crest have shown that Pax-3 can modulate the expression of cell-adhesion molecules. The failure of trunk neural crest cells to migrate is associated with abnormally high levels of N-CAM proteins, some of which are incorrectly processed (Moase and Trasler, 1991) and the ectopic expression of versican, a chondroitin sulphate proteoglycan, which inhibits neural crest migration (Henderson et al., 1997) . In a normal embryo, Pax-3 and versican are expressed in complementary domains along pathways of trunk neural crest migration and it is proposed that Pax-3 negatively regulates versican expression, therefore allowing neural crest migration (Henderson et al., 1997) . It is possible that Pax-3 may affect facial development by modulating cranial neural crest migration.
The small eye (Sey) mice and rat mutants are due to a mutation in Pax-6 (Hill et al., 1991; Matsuo et al., 1993) . These animals have abnormalities of the eyes and nasal pits and an ectopic bar of cartilage forms which is thought to substitute for the lateral nasal capsule (Fig. 4 ; Table 2 ; Kaufman et al., 1995; Osumi-Yamashita et al., 1997) . Studies in Sey rat embryos have shown that the anterior midbrain crest migrates abnormally (Matsuo et al., 1993; Osumi-Yamashita et al., 1997) and studies of Sey mice have suggested that some of this crest population dies during migration (Grindley et al., 1995) . Pax-6 is not expressed in the anterior midbrain crest cells, but it is expressed in the rostral head ectoderm and forebrain, suggesting that environmental cues for migration are abnormal in the Sey mutants. This has been confirmed by heterotopic crest transplants in which labelled mutant midbrain crest have been grafted into wildtype host embryos and vice versa. In wildtype hosts, mutant cells migrate along the normal pathway whereas the wildtype cells migrate abnormally in the mutant hosts (Osumi-Yamashita et al., 1997). Therefore, secreted molecules which control neural crest migration appear to be altered in Sey mutants. Furthermore, other experiments have shown that wildtype cells and mutant cells do not mix in chimeric mice, again suggesting that there are cell surface changes in Sey mutants . Candidate genes that may be affected include those encoding cell-adhesion molecules, which are known to be important in neural crest migration, and some of which have promoters that can bind members of the Pax gene family (reviewed by Bronner-Fraser, 1993; Kozmik et al., 1992; Chalepakis et al., 1994; Holst et al., 1997) . In the Pax-7 knockout, as with the Pax-6 mutant, development of the nasal septum/capsule is affected and in addition, the maxillary bone is reduced in size ( Fig. 4 ; Table 2 ; Mansouri et al., 1996) .
As with the naturally occurring Pax-3 and Pax-6 mouse mutations, there are human syndromes due to mutation in these genes. In humans, haplo-insufficiency of PAX6 results in Aniridia, a complete or partial absence of the iris (Nelson et al., 1984; Ton et al., 1991) , or Peter's anomaly (Hanson et al., 1994) . Haplo-insufficiency of PAX3 in humans, due to missense mutations or deletions in the PAX3 gene, results in Waardenburg's syndrome type 1, characterized by deafness and some craniofacial anomolies (Tassabehji et al., 1992) . A distinct syndrome, craniofacial-deafness-hand syndrome, which includes deafness and hypoplasia of the nasal bones, is due to an asparagine to lysine mutation in the paired box domain of PAX3 (Asher et al., 1996b) . Interestingly, mutation of the same amino-acid, but this time to histidine, results in Waardenburg syndrome type 3, which is not characterized by the loss or hypoplasia of the nasal bone (Hoth et al., 1993) . Another paired-class homeobox-containing gene is Cart-1. In rat embryos, Cart-1 is expressed in the early developing head mesenchyme, later the branchial arches and finally in regions of chondrogenesis (Zhao et al., 1994) . In mice, knockout of Cart-1 results in a hypoplastic facial skeleton and the loss of the cranial vault, the latter associated with a failure of the neural tube to close at the midbrain level . The early migrating neural crest appears to be normal, but there is increased apoptosis of the forebrain mesenchymal cells, which may account for the development of some of the hypoplastic facial structures, suggesting that Cart-1 is needed for survival of some cells.
Other transcription factors
Other transcription factors that are not homeobox-containing genes but which have been shown to have a role in facial development include Glis (discussed above), twist, ski and AP-2. Twist is a transcription factor containing a basic helix-loop-helix motif which is expressed in the mesenchyme of the mouse developing face, with high levels of expression in the first arch (Wolf et al., 1991; Füchtbauer, 1995; Stoetzel et al., 1995; Gitelman, 1997) . Knockout of twist function in mice is lethal before E10.5. The developmental defects include failure of the neural tube to close, abnormal head mesenchyme and branchial arch formation (Chen and Behringer, 1995) . In humans, Saethre-Chotzen syndrome, characterized by cleft palate, abnormal nasal septum formation, maxillary hypoplasia and craniosynostosis, is due to mutation of one copy of the TWIST gene (El Ghouzzi et al., 1997; Howard et al., 1997) .
AP-2 (activating protein-2) is expressed in the cranial neural crest, with knockout of its function in mice resulting in severely hypoplastic facial skeletal structures, which are separated at the midline and exencephaly (Schorle et al., 1996; Shen et al., 1997) . Migration of the neural crest cell populations appears to be normal in these mice. However, there is increased cell death in the branchial arches, suggesting that later phases of facial development are affected, possibly epithelial-mesenchymal interactions. The midline defects appear to be due to failure of the neural plate to fold correctly, which may be due to increased apoptosis which occurs in the Ap-2 mutants (Schorle et al., 1996) . AP-2 is thought to have a number of roles during development, including regulating matrix synthesis, apoptosis and Msx-1 gene expression, although in the Ap-2 knockout, Msx-1 expression appears to be unchanged in the facial primordia at E10.5 (Schorle et al., 1996 ; reviewed by Morriss-Kay, 1996) . The abnormalities in facial development in the Ap-2 knockout may be due to changes in a number, if not all, of these processes (reviewed by Morriss-Kay, 1996) . N-CAM expression is increased in the neural tube of Ap-2 mutants. Interestingly, Pax-3 mutants also have increased levels of N-CAM expression in the trunk neural tube. Furthermore, the eye defect in Ap-2 mutants has some similarities to that in the Pax-6 mutant (reviewed by Morriss-Kay, 1996) . This may suggest that Pax and Ap-2 expression are part of a common pathway in some regions of embryonic development.
Knockout of ski, a proto-oncogene, has a similar phenotype to Ap-2, i.e. exencephaly and facial clefting, but in contrast only a few of the skull bones are severely affected (Berk et al., 1997) . However, as with the Ap-2 knockout, derivatives of the mandibular skeleton are less affected than more anterior regions. Analysis of E9.5 mutant embryos shows that there is increased apoptosis of the cranial neural tube and craniofacial mesenchyme, with predominant celldeath in the frontonasal mass region. This is in contrast to the Ap-2 mutant, where predominant apoptosis is detected in the midbrain/hindbrain region, which is associated with the forming branchial arches (Schorle et al., 1996) . As with the Ap-2 mutant, neural crest migration appears normal.
Another gene that is involved in facial development is treacle which is predicted to encode a phosphorylated nuclear protein (Wise et al., 1997) . Mutation of this gene is thought to be responsible for Treacher-Collins syndrome, characterized by hypoplasia of some skeletal structures derived from the first arch, cleft palate and ear abnormalities (Dixon et al., 1996) . The expression of this gene during facial development is not known, so it is unclear which stages of facial development are affected by mutation of this gene.
Signalling interactions
To understand facial development, we need to know which signalling pathways co-ordinate facial outgrowth and patterning, and how these signalling pathways are integrated. It is clear that many factors expressed in the face also have other roles during vertebrate development and there are likely to be similar signalling cascades. However, much of the vertebrate head arose through the evolution of the cranial crest (for a review see Gans and Northcutt, 1983) and although some functions of genes and their homologues have been conserved during evolution (for example, eyeless and Pax-6 during the development of the eye in Drosophila and mice, respectively) it is as yet unclear if all the signalling cascades have been conserved and whether there are any novel factors which are involved in face development.
Outgrowth of the facial primordia is dependent on epithelial-mesenchymal signalling interactions (Wedden, 1987; Richman and Tickle, 1992) , but the role of these interactions in controlling patterning is unknown and there is still very little data about which signalling factors can regulate the expression of the homeobox-containing genes. For example, although we know that FGFs can partially maintain outgrowth of the facial primordia, we do not yet know which genes are regulated by FGF expression. However, we do know that BMP-2 and BMP-4 can activate/maintain the expression of Msx-1 and Msx-2 in the mesenchyme in the developing facial primordia ( Fig. 3C ; Barlow and FrancisWest, 1997) . Furthermore, in the maxillary primordium, ectopic application of BMP-2 and BMP-4 can extend the expression of Msx-1 in the mesenchyme, which is associated with an extension of Shh in the overlying epithelium ( Fig. 3C,D ; Barlow and Francis-West, 1997). As Shh probably activates the expression of Bmp-2 in the maxillary mesenchyme, there may be a signalling loop between Shh in the epithelium and Bmp-2 and Msx-1 in the underlying mesenchyme. In the chick mandibular primordia, Shh expression is not detectable until much later in development and therefore, Shh is unlikely to have a role in patterning and growth of the chick mandibular primordia. However, in the mandibular primordia, ectopic application of BMP-2 or BMP-4 can extend the expression of Msx-1 in the mesenchyme and Fgf-4 in the overlying epithelium, suggesting that there is a signalling loop between mesenchymal expression of Bmp-2 and epithelial expression of Fgf-4 (Barlow and Francis-West, 1997) .
Recombination experiments between facial mesenchyme and limb ectoderm have shown that, overall, the epithelium is interchangeable and reasonable development/differentiation can occur in all the facial primordia with ectopic epithelia (Richman and Tickle, 1989) . Furthermore, facial mesenchyme, unlike flank mesenchyme, is able to maintain the structure of the AER for at least 48 h (Richman and Tickle, 1992) . The AER is a region of thickened ectoderm normally responsible for maintaining outgrowth of the developing limb bud. This ability of facial mesenchyme to maintain the AER in particular, suggests that there are at least some common epithelial-mesenchymal signalling pathways between developing limb buds and facial primordia. Molecules which are involved in signalling interactions that are expressed in both the AER and facial epithelium include jagged 2, genes are expressed in the mesenchyme of both the limbs and facial primordia. The ability of BMP-2 to extend the epithelial expression of Fgf-4 in the mandibular primordia is also seen in the developing limb bud, again indicating that there are parallels in the signalling cascades (Duprez et al., 1996; Barlow and Fran-cis-West, 1997 ). However, experiments in which maxillary mesenchyme has been grafted into the developing limb and vice versa have suggested that the signalling interactions are not totally identical (Brown et al., 1993) . This idea is supported by comparing the expression of some of the putative key players such as Shh, Bmp-2, Fgfs and Msx in relation to each other in the developing face and limb. Furthermore, at least one important signalling molecule in limb development, Wnt-7a, is not expressed in the chick developing facial primordia (Francis-West, unpublished data). However, in the latter case, it is possible that other members of the Wnt gene family which are expressed in the developing facial primordia have equivalent roles to Wnt-7a in the developing limb bud.
As facial structures and teeth both arise by signalling interactions between the epithelium and ectomesenchyme, studies performed on the developing tooth also may provide insight into signalling networks that co-ordinate facial development. In the developing tooth bud, both BMP-2/-4 and members of the FGF family can activate/maintain mesenchymal expression of Msx-1 and Msx-2 (Vainio et al., 1993; Chen et al., 1996) . In addition, BMP-4 can activate Bmp-4 and the transcription factors, Lef-1 and Egr-1. Whilst both FGFs and BMPs can activate/maintain Msx gene expression and require Msx gene function to mediate some of their effects, they can also act differentially in their ability to activate other genes (Chen et al., 1996) . For example, BMPs can induce/maintain notch-1, -2 and -3, but not jagged 1, gene expression, whilst FGFs have the converse effect . BMPs and FGFs also act differentially in their ability to activate Pax-9 expression. FGF-8 induces Pax-9 expression but BMP-4 prevents this induction, suggesting that the two signalling pathways are antagonistic (Neubüser et al., 1997) . Pax-9 appears to define the presumptive tooth mesenchyme, suggesting that BMP-4/ FGF-8 signalling may determine this region (Neubüser et al., 1997) . Interestingly, there is a similar complementary pattern of Bmp-4 and Fgf-8 expression in the chick developing maxillary and mandibular primordia ( Fig. 5C,D ; Bogardi, Barlow and Francis-West, unpublished data) . How this differential expression of Fgf-8 and Bmp-4 affects gene expression in the underlying mesenchyme and subsequent development of these primordia, remains to be determined but it suggests that antagonistic interactions between BMP and FGF signalling may have a more general role in development.
Very little is known about the Wnt signalling pathway during facial development; the expression patterns of the Wnt gene family members still needs to be fully determined. Functional studies also need to be performed to determine if there is a signalling loop between Wnt and Shh gene expression, as there is in the developing limb bud, which may control outgrowth and patterning of the developing facial primordia. Alternatively, Shh and members of the Wnt gene family may act synergistically, as they do during the induction of myogenesis during somite development (Münster-berg et al., 1995) .
Most functional studies of signalling interactions that control homeobox gene expression during facial development have focused on the Msx gene family, but the signalling factors that regulate Dlx and most other homeobox gene expression in the developing facial primordia are not known. It will be important to analyse these signalling interactions, not only because Dlx genes are important in patterning, but because recent studies have shown that members of the Msx gene family can form heterodimers with members of the Dlx family, and with other transcription factors such as Miz1 (Wu et al., 1997; Zhang et al., 1997) . Dlx/Msx heterodimers have different transcriptional activities in vitro than homodimers. Since members of the Msx and Dlx gene families are expressed in overlapping domains during facial development (Zhang et al., 1997) , fates of different regions of the developing facial primordia may be determined by the specific gene combinations that they express. To understand facial patterning, we will need to identify the signalling factors that maintain or induce the expression of these homeobox-containing genes and then determine how the expression of these genes influences facial development.
Patterning of the facial primordia-neural crest versus environmental signals?
Patterning of the developing face is probably controlled by co-ordinated signalling between the mesenchyme and epithelium, as in many other vertebrate structures. However, the individual roles of these tissues in patterning the facial primordia are far from understood. Furthermore, different mechanisms may pattern different axial levels. The results from a number of studies suggest that at least some patterning information is inherent to even premigratory neural crest cells. When an anuran (toad) cephalic neural fold was transplanted to a urodele (newt) host, the visceral arch skeleton which developed on the operated side was of characteristically donor morphology, despite having developed in a host mesoderm and epithelial branchial arch environment (Wagner, 1949) . Furthermore, Horstadius and Sellman (1946) reciprocally transplanted mandibular and gill arch neural crest by rotation of the neural plate in another urodele and found that, while each could follow the others' migratory routes, some morphological features of the cartilaginous elements which developed were more appropriate to the original source of the neural crest than to their new location, particularly with respect to fusion with other cartilaginous elements. Even more striking are the results of Noden (1983) regarding heterotopic transplantations of quail or chick premigratory first arch neural crest to chick second or third arch levels. Graft-derived ectopic cartilages and bones developed in virtually all cases; the shapes and arrangements of these elements were highly characteristic of proximal mandibular arch elements.
This neural crest pre-patterning hypothesis is complicated, however, by the finding that rostral mesencephalic neural crest, which normally forms maxillary, periocular and frontonasal skeletal structures, produce the same supernumerary mandibular arch elements as rostral metencephalic neural crest (the normal source of the mandibular elements) when transplanted to second or third arch levels (Noden, 1983) . Furthermore, transplantation of mandibular neural crest to more rostral levels (Noden, 1978) results in a normal head skeleton, although the same graft would produce ectopic mandibular structures if transplanted caudally. This shows that in the chick, in addition to the first arch crest, the crest which gives rise to structures anterior of the mandible is 'pre-patterned' to form mandibular structures. However, normally this 'mandibular pre-patterning' is modified by environmental signals during development to form the anterior structures of the head (Noden, 1983) .
The pre-patterning of the first arch crest is not absolute. For example, in the majority of cases with supernumerary mandibular elements, normal second and third arch structures were also produced, with most being of chimeric donor/host origin (Noden, 1983) . This again suggests that environmental signals can modify the fate of the crest. There may also be a population effect, whereby respecification can occur, but only if the population of ectopic neural crest cells is not too large. Another technique to divert neural crest cells to ectopic arches is the extirpation of premigratory neural crest, which subsequently regenerates to yield a normal skeleton. Labelling studies have shown that under certain conditions, the regenerated neural crest cells are derived from neural crest immediately adjacent to the excised region, both anterior and posterior (Couly et al., 1996; Saldivar et al., 1997) . In one such study (Couly et al., 1996) , first arch crest cells repopulated the second arch, either in its entirety, or in combination with neural crest cells derived from caudal hindbrain levels. Second arch elements developed normally in all cases and supernumerary mandibular elements were not observed, implicating the arch environment for control of patterning. However, regulated neural crest cells may have different properties to those from which they were derived; neural crest ablation has been shown to alter gene expression of neural crest cells even at a distance from the ablation site, prior to their emigration (Saldivar et al., 1997) . The first arch-derived cells that repopulated the second arch after ablation may therefore have lost original pre-patterning information and /or become more susceptible to environmental cues.
Two more lines of evidence suggest that the environment can alter the fate of the crest. In neural crest rotation studies in which second and third arch neural crest were reciprocally redirected, normal second arch structures were formed, but there was an almost complete absence of third arch structures (Saldivar et al., 1997) . In both cases, the crest populations do not appear to be pre-patterned and the normal development of the second arch from third arch crest suggests that environmental signals are important in patterning. However in this case, the third arch environment is not sufficient to promote third arch skeletogenesis from second arch crest. The different results in the two arches following introduction of ectopic neural crest may be due to actual specific differences in the neural crest populations or arch environments, or may be a function of the direction of transplantation, i.e. neural crest cells may be more difficult to respecify when transplanted caudally than rostrally. In another study, early and late migrating crest have been shown to have equivalent potential, forming structures appropriate to their new environment when transplanted into older or younger hosts (Baker et al., 1997) . All this data suggests that the neural crest is plastic and can respond to environmental signals changing fate under the appropriate circumstances. These signals could be from the adjacent neural tube or neural crest populations. Alternatively, the cranial neural crest may receive signals from the mesoderm or ectoderm. Ectoderm could also directly pattern skeletal structures by the localized production of factors which could either entrap determined chondrogenic cells, or directly promote chondrogenesis in underlying neural crest cells. Type II collagen expression is found in a pattern which prefigures the future elements of the neurocranium, at stages when chondrogenesis-promoting interactions are known to be occurring (Thorogood et al., 1986; Wood et al., 1991) . It has been proposed as a candidate molecule with a major role in this model, although other molecules would also have to be involved to explain its presence in non-chondrogenic regions of the embryo. However, this model is specific for patterning neurocranial elements and would not apply to the visceral skeleton (reviewed by Hanken and Thorogood, 1993; Thorogood, 1993) .
At later stages of development, the epithelium probably has an, as yet, unidentified role in controlling patterning of the visceral structures. Whether or not the neural crest cells are pre-patterned, they could still induce/maintain the expression of factors which have a role in patterning. Support for this possibility comes from work by Hunt et al. (1991c) , who showed that Hoxb-2 is initially expressed in the migrating neural crest cells of the second arch, but is subsequently also expressed in the ectoderm overlying the Hoxb-2 expressing mesenchyme. Alternatively, the paraxial mesoderm may induce/maintain the expression of epithelial factors that control patterning. In either case, this would be analogous to the situation seen in the limb bud where different tissues control one aspect of patterning at different stages. During limb development, signals from the mesoderm induce the expression of En-1 and Wnt-7a in the presumptive ventral and dorsal ectoderm, respectively. These molecules subsequently control patterning of the d-v axis of the developing limb bud . Therefore, first the mesoderm, then the ectoderm have instructive roles in controlling patterning of the d-v axis of the limb.
Finally, whilst the role of the paraxial mesoderm in early signalling interactions is unknown, myogenic cells which are derivatives of the paraxial mesoderm appear to be patterned by the neural crest populations. This has been shown in experiments in which the first arch crest has been transplanted caudally. Analysis of the muscles formed from the paraxial mesoderm showed that they are appropriate to the ectopic mandibular structures (Noden, 1983) . Another study in which somitic or pre-somitic mesoderm, which normally give rise to trunk and limb muscles, was transplanted into the midbrain region, some donor myogenic cells were patterned according to the local environment again indicating that the myogenic cells have no inherent patterning ability (Noden, 1986) . Similar experiments in the developing limb bud have shown that the muscles are patterned according to their local environment. The mechanisms that control muscle patterning in both systems are far from understood. However, ET-1 may be involved in ectomesenchymeparaxial mesoderm signalling interactions in the branchial arches: Et-1 is expressed in the paraxial mesoderm whilst its receptor, EtA, has been detected in the adjacent ectomesenchyme (Maemura et al., 1996; Clouthier et al., 1998) .
Unravelling facial development
To fully understand facial patterning, we need to first understand the mechanisms which control outgrowth and patterning of the facial primordia at different stages of facial development. Second, we need to identify signalling pathways involved in these processes. Ultimately, we will need to know how these signalling pathways interact to co-ordinate facial development. However, there is still a lack of knowledge about very basic aspects of facial development. For example, when are the skeletal elements of the facial primordia specified/patterned? This problem is particularly evident during the development of the maxillary primordium, which gives rise to a series of bones. If we assume that some aspects of patterning must operate during outgrowth of the facial primordia, we still do not know if the skeletal elements formed from the developing maxillary primordia are patterned/specified sequentially, as occurs with the skeletal elements in the developing limb bud where the more proximal elements are specified and formed prior to the development of the distal structures. Alternatively, although less easy to envisage, the skeletal elements from the maxillary primordia may all be specified simultaneously.
We will also need to address signalling interactions dur-ing neural crest migration. For example, the environment appears to be important in patterning many of the neural crest populations. The tissues and signalling factors involved in these interactions are not known. Another question that needs to be resolved is whether the epithelium has any role in patterning the facial primordia. Whilst ectoderm-mesenchyme recombination experiments have shown that the epithelia are all interchangeable, allowing outgrowth and appropriate differentiation of cartilage or membrane bone, whether the epithelium can control facial patterning has not been fully explored. Furthermore, if the epithelium has a role in facial patterning, what are the signalling factors? Shh is expressed in the epithelium of some of the developing facial primordia and is therefore, a strong candidate but its patterning role has yet to be demonstrated.
Other fundamental questions that need to be addressed include determining how the neural crest populations influence gene expression in the epithelium once they have reached the facial primordia. For example, do different populations of crest maintain/induce the differential expression of signalling molecules in the epithelium? In the chick, during early facial development, Bmp-4 and Fgf-8 are expressed in complementary domains in both the developing mandibular and maxillary primordia (Fig. 5) . In the developing chick maxillary primordia, their expression appears to be associated with the arrival of neural crest in the forming arch suggesting the incoming crest may induce their expression (Fig. 5) . A similar association between the induction of Fgf-8 expression following the arrival of the migrating neural crest has also been reported in the mouse (Heikinheimo et al., 1994) . How are these differential expression patterns set up and are they related to the different populations of neural crest that form the primordia? In the mouse, antagonistic interactions between BMP-4 and FGF-8 signalling are thought to define the presumptive dental region in the mandibular primordia. Furthermore, more recently antagonistic BMP/FGF signalling interactions have been shown to be involved in limb and pituitary development (Buckland et al., 1998 : Ericson et al., 1998 . Thus, an understanding of how these reciprocal patterns of Bmp-4 and Fgf-8 expression are determined should give us a further understanding of facial patterning and may also give us insight into signalling interactions between different populations of crest.
The maxillary and mandibular primordia are made up of the neural crests from several distinct populations which, on the whole, remain segregated giving rise to distinct skeletal structures. However, in some regions of the developing face, distinct crest cell populations intermingle. How is patterning between these different crest populations co-ordinated, is there one crest population that is dominant, i.e. instructive over another or is it via epithelial signals? Furthermore, is there a region within the developing facial primordia analogous to the polarising region in the limb that signals to specify the development of neighbouring cells? Although, it would seem likely that there must be some such region, it has not yet been identified within any of the facial primordia and may not exist.
Finally, other unresolved questions do not relate to patterning but concern differentiation. The cranial crest, unlike the trunk crest, has chondrogenic potential and acquires it prior to migration. Furthermore, the ability to form dermal bone is exclusive to the cranial crest in higher vertebrates. We still do not understand the signalling interactions involved in these processes and yet these are fundamental to the development of the head.
Knockout approaches, overexpression and ectopic expression studies will continue to give insight into how the facial primordia are patterned, and studies in the chick, mouse and zebrafish will all contribute significantly to our understanding of facial development. The identification of promoters to specifically mis-express genes or knockout expression, via a cre/loxP system, in distinct areas of the face would be a powerful tool to study signalling interactions in facial development in mice. In addition, the identification and analysis of zebrafish mutants with craniofacial defects will also provide significant insights into signalling interactions that control facial development (Piotrowski et al., 1996; Schilling et al., 1996a) . Already such mutants have been used to determine when a gene is crucial during facial development (Schilling et al., 1996b) . The identification of the mutant genes will provide further important stepping stones to answer questions about face development.
